45 results
Chart of Inhalers for Asthma and COPD
 - SABA - Short Acting Beta-2 Agonists
 - SAMA
Combination - LABA ... LABA Combination ... www.pyrls.com #inhalers #pulmonary ... #lung #asthma # ... #respiratory #pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... Chronic Obstructive Lung ... indicate preferred treatment ... LAMA: long-acting ... #Management #Pulmonary
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... chronic obstructive pulmonary ... , long-acting β2 ... #LABA #LAMA #SABA ... #SAMA #ICS #Pharmacology
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
The 2019 Global ... Asthma (GINA) treatment ... : long-acting β2 ... Management #Stepwise #Pulmonary ... #StepUp #Treatment
Long-Acting Dual Bronchodilators - LAMA/LABA Combo Inhalers 

The FDA approved a new dual bronchodilator (LABA/LAMA) combination
Long-Acting Dual ... is approved for treatment ... according to GOLD 2019 ... #LABA #Combo #Inhalers ... #Combination #Pharmacology
COPD Preferred Treatments - GOLD 2018 

COPD is a common progressive respiratory condition that can be
COPD Preferred Treatments ... - GOLD 2018 ... inhalers that include LABA ... (long-acting beta2 ... GOLD2018 #COPD #Treatment
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Metformin Treatment ... Diabetes Care 2018 ... #CKD4 #Dosing #Pharmacology ... #VisualAbstract
A quick infographic describing some of the common reversal agents used by anesthesiologists, their mechanism of
anesthesiology #treatment ... amp; Mishra, R. (2015 ... anaesthesia and critical ... Pharmacology of ... neuromuscular pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 ... daily The 2019 ... recommendations for the treatment ... won’t have any clinical ... #Indications #Pharmacology
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
the FDA for the long-term ... treatment of Obesity ... WeightLoss #AACE #2016 ... #Pharmacology #